52 results
Page 2 of 3
6-K
EX-99.3
temlc 0smhsezt
14 Nov 22
VBL Therapeutics Reports Third Quarter 2022 Financial Results
4:19pm
6-K
EX-99.3
y2rncg sjudv
15 Aug 22
VBL Therapeutics Announces Second Quarter 2022 Financial Results
4:07pm
6-K
EX-99.3
n84gy9d 960
17 May 22
VBL Therapeutics Reports First Quarter 2022 Financial Results
7:00am
424B5
w40r ph8i8baxroa
11 Feb 22
Prospectus supplement for primary offering
5:28pm
6-K
EX-99.2
xrwyw5hjidk0rqgdw
2 Sep 21
Notice of Annual General Meeting of Shareholders
7:20am
424B8
wbyq3kjb5srl6o2w4kc
19 Apr 21
Prospectus unintentially filed late
5:06pm
6-K
EX-1.1
53m 452t5bf3b4hqx
12 Apr 21
Vascular Biogenics Ltd. Prices Public Offering of Ordinary Shares and Pre-Funded Warrants
9:10am
6-K
EX-99.1
shs rdz40g1j
15 Jan 21
Ordinary Share Purchase Agreement
7:01am
6-K
EX-99.2
0ypuim
15 Jan 21
Ordinary Share Purchase Agreement
7:01am
6-K
EX-10.1
t1bx2o9 xrdyhw
12 May 20
Current report (foreign)
12:04pm
6-K
EX-10.1
f2w8dukv lqk
11 May 20
VBL Therapeutics Announces $10.0 Million Registered Direct Offering
9:23am
6-K
EX-10.1
lf42ie7
17 May 19
Current report (foreign)
5:20pm
424B5
0m4jxu i1yetqyp2i
17 May 19
Prospectus supplement for primary offering
5:19pm
424B5
2p8puowflnnh7cm
27 Jun 18
Prospectus supplement for primary offering
9:30am
6-K
EX-1.1
2akp2s3f
27 Jun 18
VBL Therapeutics Announces $15.5 Million Registered Direct Offering Priced At-the-Market
9:29am